INDOMETHACIN AND DISODIUM ETIDRONATE FOR THE PREVENTION OF RECURRENCE OF HETEROTOPIC OSSIFICATION AFTER SURGICAL RESECTION - 2 CASE-REPORTS

被引：15

作者：

BIERINGSORENSEN, F

TONDEVOLD, E

机构：

[1] Centre for Spinal Cord Injured, Department TH and Department of Orthopedic Surgery U, Rigshospitalet, National University Hospital, Copenhagen

来源：

PARAPLEGIA | 1993年 / 31卷 / 08期

关键词：

SPINAL CORD INJURY; HETEROTOPIC OSSIFICATION; SURGERY; DISODIUM ETIDRONATE; INDOMETHACIN;

D O I：

10.1038/sc.1993.83

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Two spinal cord injured patients had extensive heterotopic ossifications around their hips surgically removed. The use of disodium etidronate from 2 weeks presurgery to 2-5 months postsurgery and in particular indomethacin 25 mg twice daily, from 2 weeks prior to surgery to 6 weeks postsurgery may have helped to prevent recurrence of the ossifications in the follow up periods of 4 and 5 years respectively.

引用

页码：513 / 515

页数：3

共 23 条

[1]

Blane C.E., Perkash I., True heterotopic bone in the paralyzed patient, Skeletal Radiol, 7, pp. 21-25, (1981)

[2]

Hsu J.D., Sakimura I., Stauffer E.S., Heterotopic ossification around the hip joint in spinal cord injuredpatients, Clin Orthop, 112, pp. 165-169, (1975)

[3]

Knudsen L., Lundberg D., Ericsson G., Myositis ossificans circumscripta in para-/tetraplegics, Scand]Rheumatol, 11, pp. 27-31, (1982)

[4]

Tibone J., Sakimura I., Nickel V.L., Hsu J.D., Heterotopic ossification around the hip in spinalcord-injured patients, A Long-Term Follow-Up Study.] Bone Joint Surg, 60A, pp. 769-775, (1978)

[5]

Venier L.H., Ditunno J.F., Heterotopic ossification in the paraplegic patient, Arch Phys Med Rehabil, 51, pp. 475-479, (1971)

[6]

Wharton G.W., Heterotopic ossification, Clin Orthop, 152, pp. 142-149, (1975)

[7]

Wittenberg R.H., Peschke U., Botel U., Heterotopic Ossification after Spinal Cord Injury.] Bone]ointSurg, 74B, pp. 215-218, (1992)

[8]

Garland D.E., Orwin J.F., Resection of heterotopic ossification in patients with spinal cord injuries, Clin Orthop, 242, pp. 169-176, (1989)

[9]

Ts L., Bauer F., Rindell K., High doses of the diphosphonate EHDP for the prevention ofheterotopic ossification. An experimental and clinical study, Scand] Rheumatol, 16, pp. 33-39, (1987)

[10]

Stover S.L., Niemann K., Miller J.M., Disodium Etidronate in the Prevention of postoperativerecurrence of Heterotopic Ossification in Spinal-Cord Injury Patients.] Bone Joint Surg, 58A, pp. 683-688, (1976)

← 1 2 3 →